Researchers have found that only about one in 10 common non-surgical and non-invasive treatments for lower back pain is effective.
An international team conducted a pooled data analysis of the available research and published the results online in BMJ Evidence Based Medicine today (19 March).
The paper’s first author Aidan Cashin from the Centre for Pain IMPACT, Neuroscience Research Australia, Randwick, New South Wales and the School of Health Sciences at the University of New South Wales in Sydney, Australia
Dr Cashin and his colleagues suggest that the pain relief offered by the treatment options they focused on is only marginally better than that achieved with a placebo.
Low back pain is common and debilitating, and 80-90 per cent of it is categorised as ‘non-specific’, because there’s no immediately identifiable cause, they note.
Non-surgical and non-invasive approaches are recommended as the initial treatment approach. But many such options are available, and it’s not always easy to know which ones are effective, point out the researchers.
To build on the evidence base, the researchers scoured research databases for published randomised placebo-controlled trials of non-surgical and non-interventional treatments for people with non-specific low back pain, with the aim of pooling the results.
Focus on pharmacological and non-pharmacological approaches
The approaches included were pharmacological, such as non-steroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants, and non-pharmacological, such as exercise, massage, and spinal manipulation.
In total, 301 trials investigating 56 different treatments or treatment combinations were included in the pooled data analysis. The trials were carried out in a total of 44 countries in Africa, North America, South America, Asia, Australia and Europe.
The most common interventions were NSAIDs (27 trials), opioids (26 trials), laser and light therapy (25), acupuncture (24), and gentle manual therapy (mobilisation; 19 trials).
The researchers note that 52 trials sampled participants with acute low back pain; 228 trials with chronic low back pain; and 21 trials participants with both types. Pain intensity was most often assessed using the Visual Analogue Scale or the Numeric Rating Scale.
‘There is a clear need for large, high-quality, placebo-controlled trials to reduce uncertainty in efficacy estimates for many non-surgical and non-interventional treatment’ [Aidan Cashin et al]
Of the 69 treatment comparisons included in the trials, the certainty of the evidence was moderate for 11 (16 per cent), low for 25 (36 per cent), and very low for 33 (48 per cent), as assessed by the GRADE system.
The pooled data analysis showed that compared with placebo, no non-pharmacological treatments and only NSAIDs emerged as effective for acute low back pain; exercise, spinal manipulation, and taping, antidepressants and drugs that target pain receptors (TRPV1 agonists) emerged as effective for chronic low back pain. However, the effects were small, the researchers note.
Moderate quality evidence showed that treatments for acute low back pain that weren’t effective included exercise, steroid injections and paracetamol, while anaesthetics (i.e. Lidocaine) and antibiotics weren’t effective for chronic low back pain, the analysis showed.
The evidence was inconclusive for 10 non-pharmacological and 10 pharmacological treatments for acute low back pain. It was also inconclusive for a wide range of 22 non-pharmacological treatments, including acupuncture, massage, osteopathy and TENS, and 16 pharmacological treatments, including antidepressants plus paracetamol, complementary medicines, bisphosphonates and muscle relaxants for chronic back pain.
Conclusions and caveats
Dr Cashin and his colleagues point out that many of the available trials included only a few participants and reported inconsistent results, added to which, the type and quality of some of the placebos used varied considerably, potentially affecting the certainty of the findings.
But they say: ‘Our review did not find reliable evidence of large effects for any of the included treatments, which is consistent with clinical guidelines and our previous review. While we would like to provide more certain recommendations for where to invest and disinvest in treatments, it is not possible at this time.’
In addition, the researchers emphasise: ‘There is a clear need for large, high-quality, placebo-controlled trials to reduce uncertainty in efficacy estimates for many non-surgical and non-interventional treatments.’
The full version of the article is titled Analgesic effects of non-surgical and non-interventional treatments for low back pain: a systematic review and meta-analysis of placebo-controlled randomised trials Doi: 10.1136/bmjebm-2024-112974 – see: https://ebm.bmj.com/lookuu/doi/10.1136/bmjebm-2024-112974
Image: Shutterstock